Article Details
Retrieved on: 2024-09-30 20:16:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
400 subject sentinel portion of Phase 2b study will evaluate the safety, immunogenicity and efficacy of Vaxart's next generation oral pill ...
Article found on: investors.vaxart.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here